TY - JOUR
T1 - Non-Invasive Prediction of High-Risk Varices in Patients with Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
AU - Moctezuma-Velazquez, Carlos
AU - Saffioti, Francesca
AU - Tasayco-Huaman, Stephanie
AU - Casu, Stefania
AU - Mason, Andrew
AU - Roccarina, Davide
AU - Vargas, Victor
AU - Nilsson, Jan Erick
AU - Tsochatzis, Emmanuel
AU - Augustin, Salvador
AU - Montano-Loza, Aldo J.
AU - Berzigotti, Annalisa
AU - Thorburn, Douglas
AU - Genesca, Joan
AU - Abraldes, Juan Gonzalez
PY - 2019/3/1
Y1 - 2019/3/1
N2 - © 2018 by The American College of Gastroenterology. BACKGROUND:Baveno-VI guidelines recommend that patients with compensated cirrhosis with liver stiffness by transient elastography (LSM-TE) <20 kPa and platelets >150,000/mm3 do not need an esophagogastroduodenoscopy (EGD) to screen for varices, since the risk of having varices needing treatment (VNT) is <5%. It remains uncertain if this tool can be used in patients with cholestatic liver diseases (ChLDs): primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC). These patients may have a pre-sinusoidal component of portal hypertension that could affect the performance of this rule. In this study we evaluated the performance of Baveno-VI, expanded Baveno-VI (LSM-TE <25 kPa and platelets >110,000/mm3), and other criteria in predicting the absence of VNT.METHODS:This was a multicenter cross-sectional study in four referral hospitals. We retrospectively analyzed data from 227 patients with compensated advanced chronic liver disease (cACLD) due to PBC (n = 147) and PSC (n = 80) that had paired EGD and LSM-TE. We calculated false negative rate (FNR) and number of saved endoscopies for each prediction rule.RESULTS:Prevalence of VNT was 13%. Baveno-VI criteria had a 0% FNR in PBC and PSC, saving 39 and 30% of EGDs, respectively. In PBC the other LSM-TE-based criteria resulted in FNRs >5%. In PSC the expanded Baveno criteria had an adequate performance. In both conditions LSM-TE-independent criteria resulted in an acceptable FNR but saved less EGDs.CONCLUSIONS:Baveno-VI criteria can be applied in patients with cACLD due to ChLDs, which would result in saving 30-40% of EGDs. Expanded criteria in PBC would lead to FNRs >5%.
AB - © 2018 by The American College of Gastroenterology. BACKGROUND:Baveno-VI guidelines recommend that patients with compensated cirrhosis with liver stiffness by transient elastography (LSM-TE) <20 kPa and platelets >150,000/mm3 do not need an esophagogastroduodenoscopy (EGD) to screen for varices, since the risk of having varices needing treatment (VNT) is <5%. It remains uncertain if this tool can be used in patients with cholestatic liver diseases (ChLDs): primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC). These patients may have a pre-sinusoidal component of portal hypertension that could affect the performance of this rule. In this study we evaluated the performance of Baveno-VI, expanded Baveno-VI (LSM-TE <25 kPa and platelets >110,000/mm3), and other criteria in predicting the absence of VNT.METHODS:This was a multicenter cross-sectional study in four referral hospitals. We retrospectively analyzed data from 227 patients with compensated advanced chronic liver disease (cACLD) due to PBC (n = 147) and PSC (n = 80) that had paired EGD and LSM-TE. We calculated false negative rate (FNR) and number of saved endoscopies for each prediction rule.RESULTS:Prevalence of VNT was 13%. Baveno-VI criteria had a 0% FNR in PBC and PSC, saving 39 and 30% of EGDs, respectively. In PBC the other LSM-TE-based criteria resulted in FNRs >5%. In PSC the expanded Baveno criteria had an adequate performance. In both conditions LSM-TE-independent criteria resulted in an acceptable FNR but saved less EGDs.CONCLUSIONS:Baveno-VI criteria can be applied in patients with cACLD due to ChLDs, which would result in saving 30-40% of EGDs. Expanded criteria in PBC would lead to FNRs >5%.
KW - Adult
KW - Aged
KW - Cholangitis, Sclerosing/blood
KW - Cross-Sectional Studies
KW - Elasticity Imaging Techniques
KW - Endoscopy, Digestive System
KW - Esophageal and Gastric Varices/diagnosis
KW - False Negative Reactions
KW - Female
KW - Humans
KW - Liver Cirrhosis, Biliary/blood
KW - Liver Cirrhosis/blood
KW - Liver/diagnostic imaging
KW - Male
KW - Middle Aged
KW - Platelet Count
KW - Prevalence
KW - Retrospective Studies
KW - Risk Assessment
UR - http://www.mendeley.com/research/noninvasive-prediction-highrisk-varices-patients-primary-biliary-cholangitis-primary-sclerosing-chol
U2 - 10.1038/s41395-018-0265-7
DO - 10.1038/s41395-018-0265-7
M3 - Article
C2 - 30315285
SN - 0002-9270
VL - 114
SP - 446
EP - 452
JO - American Journal of Gastroenterology
JF - American Journal of Gastroenterology
ER -